Over the past five years, AI has supercharged drug discovery. Algorithms now routinely identify new compounds, predict protein folding, and simulate early-stage efficacy, all in silico. Billions of dollars have poured into AI drug startups like Insitro, Xaira, and Genesis, promising faster, cheaper, and more precise development of new therapies.
Read more on AIJournal.com